The latest omicron subvariants—especially the currently dominant BA.4 and BA.5 forms—are even better at eluding vaccines and most treatments, find researchers at Columbia University.
Community outreach and restricting online scheduling to certain zip codes helped increase vaccine uptake among Black and Hispanic residents, new study says.
Columbia scientists have joined a regional consortium to accelerate the development of new drugs that target SARS-CoV-2, other coronaviruses, and viruses that could lead to future pandemics.
In the wake of the COVID pandemic, Anne Moscona is bringing an appreciation for public outreach to her upcoming role as president of the American Society for Virology.
Columbia researchers have uncovered how Gram-negative bacteria—which cause a variety of drug-resistant infections—build their protective outer layer, which could lead to more effective treatments.
On March 28, world leaders and global health experts will gather for Columbia University’s second annual Virtual Symposium on Vaccines and Global Health.
COVID patients who remain unresponsive after receiving respiratory support may require long time periods to regain consciousness; delays are related to blood oxygen levels.
Columbia has helped launch New York City’s new Pandemic Response Institute, which will develop an equitable crisis response that doesn’t leave people behind.
Computer models have helped anticipate COVID’s peaks and troughs, but models have a “cone of uncertainty” and much about the future of the pandemic remains unknown.